Detalhe da pesquisa
1.
Safety and Immunogenicity of a Randomized Phase 1 Prime-Boost Trial With ALVAC-HIV (vCP205) and Oligomeric Glycoprotein 160 From HIV-1 Strains MN and LAI-2 Adjuvanted in Alum or Polyphosphazene.
J Infect Dis
; 213(12): 1946-54, 2016 06 15.
Artigo
Inglês
| MEDLINE | ID: mdl-26908741
2.
Comparable Antigenicity and Immunogenicity of Oligomeric Forms of a Novel, Acute HIV-1 Subtype C gp145 Envelope for Use in Preclinical and Clinical Vaccine Research.
J Virol
; 89(15): 7478-93, 2015 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-25972551
3.
Construction and characterization of soluble, cleaved, and stabilized trimeric Env proteins based on HIV type 1 Env subtype A.
AIDS Res Hum Retroviruses
; 22(6): 569-79, 2006 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-16796532
4.
Human immunodeficiency virus (HIV)-specific antibody in cervicovaginal lavage specimens obtained from women infected with HIV type 1.
Clin Infect Dis
; 35(5): 611-7, 2002 Sep 01.
Artigo
Inglês
| MEDLINE | ID: mdl-12173138
5.
Detection of mucosal antibodies in HIV type 1-infected individuals.
AIDS Res Hum Retroviruses
; 18(17): 1291-300, 2002 Nov 20.
Artigo
Inglês
| MEDLINE | ID: mdl-12487817
6.
Inclusion of a CRF01_AE HIV envelope protein boost with a DNA/MVA prime-boost vaccine: Impact on humoral and cellular immunogenicity and viral load reduction after SHIV-E challenge.
Vaccine
; 30(10): 1830-40, 2012 Feb 27.
Artigo
Inglês
| MEDLINE | ID: mdl-22234262
7.
Phase I study of safety and immunogenicity of an Escherichia coli-derived recombinant protective antigen (rPA) vaccine to prevent anthrax in adults.
PLoS One
; 5(11): e13849, 2010 Nov 05.
Artigo
Inglês
| MEDLINE | ID: mdl-21079762
8.
Design and evaluation of multi-gene, multi-clade HIV-1 MVA vaccines.
Vaccine
; 27(42): 5885-95, 2009 Sep 25.
Artigo
Inglês
| MEDLINE | ID: mdl-19654066
9.
Broad immunogenicity of a multigene, multiclade HIV-1 DNA vaccine boosted with heterologous HIV-1 recombinant modified vaccinia virus Ankara.
J Infect Dis
; 198(10): 1482-90, 2008 Nov 15.
Artigo
Inglês
| MEDLINE | ID: mdl-18808335
10.
Concanavalin A binding to HIV envelope protein is less sensitive to mutations in glycosylation sites than monoclonal antibody 2G12.
Glycobiology
; 15(10): 994-1001, 2005 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-15917430
11.
Antigenic properties of peptide mimotopes of HIV-1-associated carbohydrate antigens.
J Biol Chem
; 280(32): 28959-65, 2005 Aug 12.
Artigo
Inglês
| MEDLINE | ID: mdl-15955803
12.
Protection of rhesus monkeys against infection with minimally pathogenic simian-human immunodeficiency virus: correlations with neutralizing antibodies and cytotoxic T cells.
J Virol
; 79(6): 3358-69, 2005 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-15731230
13.
Neutralizing antibodies elicited by immunization of monkeys with DNA plasmids and recombinant adenoviral vectors expressing human immunodeficiency virus type 1 proteins.
J Virol
; 79(2): 771-9, 2005 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-15613305
14.
Immunostimulatory CpG motifs induce CTL responses to HIV type I oligomeric gp140 envelope protein.
Immunol Cell Biol
; 82(5): 523-30, 2004 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-15479438
15.
Liposome-stabilized oil-in-water emulsions as adjuvants: increased emulsion stability promotes induction of cytotoxic T lymphocytes against an HIV envelope antigen.
Immunol Cell Biol
; 82(5): 531-8, 2004 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-15479439
16.
Salivary secretory leukocyte protease inhibitor is associated with reduced transmission of human immunodeficiency virus type 1 through breast milk.
J Infect Dis
; 186(8): 1173-6, 2002 Oct 15.
Artigo
Inglês
| MEDLINE | ID: mdl-12355371
17.
Performance of the OraQuick rapid antibody test for diagnosis of human immunodeficiency virus type 1 infection in patients with various levels of exposure to highly active antiretroviral therapy.
J Clin Microbiol
; 41(5): 2153-5, 2003 May.
Artigo
Inglês
| MEDLINE | ID: mdl-12734265
18.
Induction of primary virus-cross-reactive human immunodeficiency virus type 1-neutralizing antibodies in small animals by using an alphavirus-derived in vivo expression system.
J Virol
; 77(5): 3119-30, 2003 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-12584337
19.
Cellular immunity elicited by human immunodeficiency virus type 1/ simian immunodeficiency virus DNA vaccination does not augment the sterile protection afforded by passive infusion of neutralizing antibodies.
J Virol
; 77(19): 10348-56, 2003 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-12970419